+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 45Years - 55Years
All Genders
Healthy Volunteers
ID07820800

Evaluating NMR Metabolomics Risk Assessment and Digital Lifestyle Interventions for Cardiometabolic Health in Middle-Aged Adults A Population Study with Randomized Digital Health Programs

Led by University of Eastern Finland · Updated on 2026-10-06

1400

Participants Needed

1

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying middle-aged adults living in the Eloisa region of South Savo, Finland, to assess risk for five interrelated cardio-renal-metabolic conditions type 2 diabetes, coronary heart disease or myocardial infarction, stroke or cerebrovascular disease, chronic kidney disease, and fatty liver disease. The study also includes a mental wellbeing assessment using the WHO-5 Well-Being Index. It aims to evaluate whether early risk identification through blood-based NMR metabolomics and subsequent risk-stratified digital health interventions can reduce future disease risk and improve wellbeing, while also estimating cost-effectiveness for the Finnish healthcare system. Participants aged 45, 50, or 55 in 2026 undergo blood testing for NMR metabolomics risk assessment and are classified as low, moderate, or high multi-disease risk. Those with moderate or high risk are randomly assigned to one of three digital health interventions for up to 12 months a habit-based lifestyle app BitHabit, a structured digital lifestyle coaching program Onnikka, or a guideline-based digital self-care pathway Oma Eloisa as the comparator. High-risk participants additionally receive a physician consultation and optimization of guideline-directed medical therapy. Low-risk participants receive their risk results and general health information but do not receive digital interventions. All participants are followed at baseline, 6 months, and 12 months. Assessments include disease-specific risk predictions, wellbeing scores, health-related quality of life, work productivity, life satisfaction, clinical diagnoses, new prescriptions, hospitalizations, and work absenteeism. Researchers also evaluate cost-effectiveness using patient-level simulations. Digital intervention adherence, completion of blood sampling, and risk report delivery are monitored throughout the study duration.

CONDITIONS

Brief Title

NMR Metabolomics-Based Risk Assessment and Stratified Digital Health Interventions in Middle-Aged Adults (PREMAP)

Research Team

J

Janne Martikainen, PhD, Professor

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here